Hester Bios

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE782E01017
  • NSEID: HESTERBIO
  • BSEID: 524669
INR
2,332.80
-13.3 (-0.57%)
BSENSE

Nov 20

BSE+NSE Vol: 5.55 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 324228,
    "name": "Hester Bios",
    "stock_name": "Hester Bios",
    "full_name": "Hester Biosciences Ltd",
    "name_url": "stocks-analysis/hester-bios",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,332.80",
    "chg": -13.3,
    "chgp": "-0.57%",
    "dir": -1,
    "prev_price": "2,346.10",
    "mcapval": "1,993.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524669,
    "symbol": "HESTERBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE782E01017",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "5.55 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/hester-bios-324228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-4269977",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/HesterBioscienc_mojoScore_4269977.png",
        "date": "2026-11-21 10:10:47",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 November 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 November 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-hold-by-marketsmojo-4257374",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/HesterBioscienc_mojoScore_4257374.png",
        "date": "2026-11-10 10:10:16",
        "description": "Hester Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 Nov 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 November 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Hester Biosciences Gains 2.25%: 2 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/hester-biosciences-gains-225-2-key-factors-driving-the-weeks-mixed-momentum-4256081",
        "imagepath": "",
        "date": "2026-11-08 09:01:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Stock opens at Rs.2,270.35, declines 1.28%</p>\n                    <p><strong>4 Nov:</strong> Strong rebound with 2.57% gain to Rs.2,318.85</p>\n                    <p><strong>5 Nov:</strong> Sharp 4.34% rise to Rs.2,419.55 on positive quarterly outlook</p>\n                    <p><strong>6 Nov:</strong> Promoter exit announcement coincides with 2.81% drop to Rs.2,351.55</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,299.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-val..."
      },
      {
        "title": "Hester Biosciences Ltd Reports Strong Quarterly Growth Amid Positive Financial Trend",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/hester-biosciences-ltd-reports-strong-quarterly-growth-amid-positive-financial-trend-4254120",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/HesterBioscienc_fintrenddot_4254120.png",
        "date": "2026-11-06 11:00:25",
        "description": "Hester Biosciences Ltd has demonstrated a marked improvement in its financial performance for the quarter ended September 2026, signalling a positive shift from a previously flat trend. The company’s revenue growth, profitability, and operational efficiency have all shown significant gains, although certain cost pressures remain a concern. This analysis delves into the recent quarterly results, compares them with historical trends, and assesses the implications for investors amid a challenging market backdrop."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-4244572",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/HesterBioscienc_mojoScore_4244572.png",
        "date": "2026-10-30 10:10:24",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 October 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-4230152",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/HesterBioscienc_mojoScore_4230152.png",
        "date": "2026-10-19 10:10:22",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 October 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-4218747",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/HesterBioscienc_mojoScore_4218747.png",
        "date": "2026-10-08 10:10:47",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 October 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-4206407",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/HesterBioscienc_mojoScore_4206407.png",
        "date": "2026-09-27 10:10:16",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 27 September 2026, providing investors with the latest insights into its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-4194959",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/HesterBioscienc_mojoScore_4194959.png",
        "date": "2026-09-16 10:10:36",
        "description": "Hester Biosciences Ltd is rated Sell by MarketsMOJO. This rating was last updated on 30 July 2026, reflecting a reassessment of the company’s outlook. However, the analysis and financial metrics presented here are based on the stock’s current position as of 16 September 2026, providing investors with the latest insights into its performance and valuation."
      }
    ],
    "total": 65,
    "sid": "324228",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/hester-biosciences-324228"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "07-Nov-2026",
      "details": "20261105 Transcript of Earnings Conference Call for Q2 & H1 FY27 Financial Results",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Nov-2026",
      "details": "20261106 Newpaper Clippings of Financial Results",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of Listing Regulations - Approved An Unsecured Loan To Foreign Wholly-Owned Subsidiary",
      "datetime": "05-Nov-2026",
      "details": "Disclosure under regulation 30 of Listing Regulations - Board of Directors approved an unsecured loan to Hester Biosciences Africa Limited Foreign wholly-owned subsidiary of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has declared <strong>110%</strong> dividend, ex-date: 14 Jul 26",
          "dt": "2026-07-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 27 Sep 12",
          "dt": "2012-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>2:5</strong> rights issue, ex-date: 29 May 06",
          "dt": "2006-05-29",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

07-Nov-2026 | Source : BSE

20261105 Transcript of Earnings Conference Call for Q2 & H1 FY27 Financial Results

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Nov-2026 | Source : BSE

20261106 Newpaper Clippings of Financial Results

Announcement Under Regulation 30 Of Listing Regulations - Approved An Unsecured Loan To Foreign Wholly-Owned Subsidiary

05-Nov-2026 | Source : BSE

Disclosure under regulation 30 of Listing Regulations - Board of Directors approved an unsecured loan to Hester Biosciences Africa Limited Foreign wholly-owned subsidiary of the Company.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Hester Biosciences Ltd has declared 110% dividend, ex-date: 14 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Hester Biosciences Ltd has announced 1:2 bonus issue, ex-date: 27 Sep 12

stock-summary
RIGHTS

Hester Biosciences Ltd has announced 2:5 rights issue, ex-date: 29 May 06